期刊文献+

髓源性抑制细胞与肺癌转移前微环境的形成 被引量:8

Myeloid-derived suppressor cells and formation of lung cancer′s premetastatic niche
下载PDF
导出
摘要 转移是恶性肿瘤导致死亡的主要原因,目前尚无针对转移的药物。转移前微环境是肿瘤发生转移前在远端器官形成的适宜"土壤",有益于循环肿瘤细胞的定植。而转移前微环境的主要特征是免疫抑制,髓源性抑制细胞是近年来发现的具有抑制特异性和非特异性免疫的重要负性调控细胞。本综述对髓源性抑制细胞在转移前微环境的作用机制及潜在的干预靶点进行总结,以期揭示髓源性抑制细胞对转移前微环境的影响,进而为干预恶性肿瘤的转移提供有效的思路。 Metastasis is the leading cause of death in malignant tumors,but there are no drugs for metastasis currently.A suitable "soil" of distant organs for the formation of metastasis is named pre-metastatic niche(PMN),which is beneficial to the colonization of circulating tumor cells.The main feature of PMN is immunosuppression,and myeloid-derived suppressor cells(MDSC) has been discovered in recent years,which plays an important negative regulatory that could inhibit specific and non-specific immunity.This review summarizes the mechanism of immunosuppressive effect of MDSC in the PMN and the potential intervention targets,in order to reveal the effect of MDSC on PMN,and to provide an effective way to intervene the metastasis of malignant tumors.
作者 罗斌 姚嘉良 田建辉 刘嘉湘 LUO Bin;YAO Jia-Liang;TIAN Jian-Hui;LIU Jia-Xiang(Department of Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2020年第9期1136-1139,1144,共5页 Chinese Journal of Immunology
基金 国家自然基金面上项目(No.81774166,No.81973517) 上海市卫生健康委员会优秀学术带头人计划(2017BR044)。
关键词 髓源性抑制细胞 转移前微环境 肺癌 肿瘤免疫微环境 区域免疫 Myeloid-derived suppressor cells Pre-metastatic niche Lung cancer Tumor immune microenvironment Regional immunity
  • 相关文献

参考文献7

二级参考文献233

  • 1Bosco, M.C, Pupp% M., Blengio, F., Fraone, T., Cappello, P., Giovarelli, M., and Varesio, L. (2008). Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213: 733-749.
  • 2Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., lafrate, M., Prayer-Galetti, T., Pagano, F., and Viola, A. (2005). Boosting antitumor rcsponses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201:1257 1268.
  • 3Bunt, S.K., Sinha, P., Clements, V.K., Leips, J., and Ostrand- Rosenberg, S. (2006). Inflammation induces myeloid-defived suppressor cells that facilitate tumor progression. J. Immunol. 176: 284-290.
  • 4Cauley, L.S., ,Miller, E.E., Yen, M., and Swain, S.L. (2000). Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J. Imlnunol. 165: 6056-6066.
  • 5Clark, C.E., Hingorani, S.R., Mick, R., Combs, C., Tuveson, D.A., and Vonderheide, R.H. (2007). Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 67: 9518-9527.
  • 6Clarke, M.E., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., Visvader, J., Weissman, I.L., and Wahl, G.M. (2006). Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66: 9339-9344.
  • 7Shojaei, F., Singh, M., Thompson, J.D., and Ferrara, N. (2008). Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. USA 105: 2640-2645.
  • 8Shojaei, F., Wu, X.M., Qu, X.P., Kowanetz, M., Yu, L.L., Tan, M., Meng, Y.G., and Ferrara, N. (2009). G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Na0. Acad. Sci. USA 106: 6742-6747.
  • 9Shojaei, F., Wu, X., Malik, A.K., Zhong, C., Baldwin, M.E., Schanz, S., Fuh, G., Gerber, H.P., and Ferrara, N. (2007a). Tumor refractoriness to anti-VEGF treatment is mediated by CDllb^-Grl^+ myeloid cells. Nat. Biotechnol. 25:911-920.
  • 10Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Bais, C., Peale, F.V., van Bruggen, N., Ho, C., Ross, J., Tan, M., Carano, R.A., Meng, Y.G., and Ferrara, N. (2007b). By8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450: 825-831.

共引文献1189

同被引文献98

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部